InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internati…
Medical - Devices
IL, Yokne'am [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared InMode Ltd. (INMD) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices Average | - - | - - | - - | 12,640.03 | 755.88 | 48.32 | 1,201.03 | 7.56 | 0.00 | -1.1966 | 0.75 | 0.4079 | -1.3043 | -0.02 | -0.05 | 4.0969 | - - | ||
| Maximum | - - | - - | - - | 175,448.00 | 5,435.00 | 492.00 | 10,509.00 | 239.00 | 0.01 | 191.2553 | 13.46 | 1.0000 | 0.6285 | 0.06 | 0.07 | 21.0359 | - - | ||
| Minimum | - - | - - | - - | 3.00 | 0.00 | -252.00 | -2,869.00 | -121.00 | 0.00 | -252.6195 | -2.66 | -2.8076 | -24.2050 | -0.17 | -0.51 | 0.0000 | - - | ||
| Zimmer Biomet Holdings, Inc. ZBH | 108.40 | -0.87 -0.80% | 1,485 vs. 1,533 | 21,579.00 | 1,889.00 | 172.00 | 78.00 | 10,509.00 | 0.8400 | 38.6089 | 0.0019 | 0.6190 | 0.0913 | 0.0137 | 0.0080 | 0.6576 | 199.00 | ||
| Inspire Medical Systems, Inc. INSP | 186.19 | 1.42 0.77% | 406 vs. 591 | 5,579.00 | 164.00 | -10.00 | -2.00 | -355.00 | -0.3400 | -155.1281 | 0.0000 | 0.8491 | -0.0610 | -0.0170 | -0.0146 | 7.1176 | 29.00 | ||
| InMode Ltd. INMD | 18.48 | 0.25 1.34% | 938 vs. 1,176 | 1,564.00 | 80.00 | 23.00 | 24.00 | 0.00 | 0.2800 | 18.7266 | 0.0000 | 0.7962 | 0.2952 | 0.0291 | 0.0266 | 12.6561 | 84.00 | ||
| Insulet Corporation PODD | 262.00 | -4.58 -1.72% | 656 vs. 624 | 18,377.00 | 441.00 | 51.00 | 63.00 | -326.00 | 0.7400 | 57.0863 | 0.0000 | 0.7016 | 0.1166 | 0.0651 | 0.0196 | 2.4785 | 70.00 | ||
| DexCom, Inc. DXCM | 74.46 | -0.78 -1.04% | 3,160 vs. 4,291 | 29,083.00 | 921.00 | 146.00 | 152.00 | 1,167.00 | 0.3800 | 91.9129 | 0.0000 | 0.6101 | 0.1590 | 0.0652 | 0.0226 | 2.4350 | 390.00 | ||
| Inari Medical, Inc. NARI | 49.75 | 0.75 1.53% | 527 vs. 897 | 2,912.00 | 143.00 | -24.00 | -14.00 | -72.00 | -0.4200 | -28.2365 | 0.0000 | 0.8681 | -0.1690 | -0.0541 | -0.0366 | 2.0912 | 58.00 | ||
| Edwards Lifesciences Corporation EW | 70.38 | 0.84 1.21% | 2,698 vs. 6,097 | 41,510.00 | 1,598.00 | 351.00 | -138.00 | 9,344.00 | 0.5800 | 40.2819 | 0.0000 | 0.7596 | 0.2202 | 0.0494 | 0.0361 | 2.3177 | 589.00 | ||
| ShockWave Medical, Inc. SWAV | 334.75 | -0.08 -0.02% | 3,947 vs. 1,246 | 12,567.00 | 218.00 | 55.00 | 27.00 | 165.00 | 1.4800 | 53.9795 | 0.0000 | 0.8711 | 0.2529 | 0.0736 | 0.0337 | 12.4946 | 37.00 | ||
| TransMedics Group, Inc. TMDX | 79.34 | 2.14 2.77% | 1,503 vs. 1,518 | 2,662.00 | 96.00 | 12.00 | -47.00 | -491.00 | 0.3700 | 49.3068 | 0.0000 | 0.6181 | 0.1259 | 0.0765 | 0.0169 | 8.6048 | 33.00 | ||
| Boston Scientific Corporation BSX | 91.50 | 1.33 1.48% | 3,306 vs. 5,869 | 134,855.00 | 3,856.00 | 492.00 | -81.00 | 1,314.00 | 0.3400 | 50.8120 | 0.0000 | 0.6865 | 0.1276 | 0.0247 | 0.0134 | 1.2943 | 1,473.00 | ||
| Abbott Laboratories ABT | 117.26 | 1.33 1.15% | 3,850 vs. 4,927 | 203,382.00 | 9,964.00 | 1,225.00 | 627.00 | 38,011.00 | 0.7100 | 39.6679 | 0.0049 | 0.5564 | 0.1229 | 0.0316 | 0.0169 | 0.9454 | 1,734.00 | ||
| Align Technology, Inc. ALGN | 228.21 | 4.34 1.94% | 475 vs. 761 | 17,036.00 | 997.00 | 105.00 | 19.00 | 2,502.00 | 1.4000 | 57.1983 | 0.0000 | 0.7051 | 0.1053 | 0.0279 | 0.0171 | 1.0166 | 74.00 | ||
| Stryker Corporation SYK | 390.14 | 4.46 1.16% | 1,135 vs. 1,171 | 148,727.00 | 5,243.00 | 788.00 | 37.00 | 17,254.00 | 2.0700 | 42.8034 | 0.0023 | 0.6073 | 0.1503 | 0.0411 | 0.0200 | 0.8454 | 381.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.